Wanjia Group Holdings Ltd. wholesales and distributes pharmaceutical and healthcare products. It operates through the Pharmaceutical Wholesale and Distribution Business; and Hemodialysis Treatment and Consultancy Service Business segments. The Pharmaceutical Wholesale and Distribution Business segment provides wholesale and distribution, logistics, and other services for a range of pharmaceutical products of domestic manufacturers and other suppliers. The Hemodialysis Treatment and Consultancy Service Business segment includes hemodialysis treatment centers and supplies hemodialysis treatment consumables and equipment. The company was founded on July 9, 2012, and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company